BIOORGANIC & MEDICINAL CHEMISTRY

期刊官网投稿通道

提出问题

友情提示：以下期刊信息可能会有更新，仅供参考，请在投稿前自行登录期刊官网仔细核实。

期刊名

BIOORGANIC & MEDICINAL CHEMISTRY

BIOORGAN MED CHEM

ISSN / eISSN

0968-0896 / 1464-3391

目标和范围

Bioorganic & Medicinal Chemistry provides an international forum for the publication of full original research papers and critical reviews on molecular interactions in key biological targets such as receptors, channels, enzymes, nucleotides, lipids and saccharides.

The aim of the journal is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents. A special feature will be that colour illustrations will be reproduced at no charge to the author, provided that the Editor agrees that colour is essential to the information content of the illustration in question.

研究方向

有机化学

生化与分子生物学

药物化学

CiteScore

6.40

查看趋势图

CiteScore 学科排名

类别	分区	排名
Chemistry - Organic Chemistry	Q2	#50/197
Chemistry - Pharmaceutical Science	Q2	#50/171
Chemistry - Drug Discovery	Q2	#59/156
Chemistry - Biochemistry	Q2	#164/428
Chemistry - Clinical Biochemistry	Q2	#44/113
Chemistry - Molecular Medicine	Q2	#78/171
Chemistry - Molecular Biology	Q2	#184/380

Web of Science 核心合集

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

类别 (Journal Citation Reports 2023)	分区
BIOCHEMISTRY & MOLECULAR BIOLOGY - SCIE	Q3
CHEMISTRY, MEDICINAL - SCIE	Q3
CHEMISTRY, ORGANIC - SCIE	Q1

H-index

142

出版国家或地区

ENGLAND

出版商

Elsevier Ltd

出版周期

Semimonthly

出版年份

1993

年文章数

331

Open Access

通讯方式

PERGAMON-ELSEVIER SCIENCE LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OX5 1GB

同领域相关热门期刊
近期发表文章

Synthesis and biological evaluation of indane-based fluorescent probes for detection of amyloid-β aggregates in Alzheimer’s disease: (2023) Hyunseung Lee, Yihoon Kim, Hira Aziz, Dong-Min Kang, Jaewoon Lee, Sujin Lee, Sunhwa Jung, Suyeon Hyeon, Hyunah Choo, Ghilsoo Nam, Yun Kyung Kim, Sungs...

Discovery of a new dihydroeugenol-chalcone hybrid with cytotoxic and anti-migratory potential: a dual-action hit for cancer therapeutics: (2023) Izadora Amaral Nakao, Tamires Cunha Almeida, Adriana Cotta Cardoso Reis, Gabrielly Guimarães Coutinho, Aline Mol Hermenegildo, Cleydson Finotti Cordei...

Design, Development and Bio-evaluation of a novel radio-ligand 99mTc-THQ-DTPA as a sigma 2 receptor specific breast tumor imaging agent: (2023) Vishakha Chaudhary, Shubhra Chaturvedi, AnjuWadhwa, Ritika Chaudhary, Divya Gautam, Deepika Sharma, Rupesh Kumar, A.K. Mishra

Review and prospects of targeted therapies for Spleen tyrosine kinase (SYK): (2023) Zhaozhao Wang, Shu Qu, Jiahao Yuan, Wen Tian, Jinglei Xu, Rui Tao, Shilong Sun, Tao Lu, Weifang Tang, Yong Zhu

Discovery of a novel GPR35 agonist with high and equipotent species potency for oral treatment of IBD: (2023) Zhaoxiang Song, Dan Lu, Jun Sun, Yangliang Ye, Jiahui Fang, Kai Wang, Shimeng Guo, Qing Zhang, He Xinheng, Xin Xie, Jianhua Shen

Synthesis, anti-inflammatory activity, inverse molecular docking, and acid dissociation constants of new naphthoquinone-thiazole hybrids: (2023) Cagla Efeoglu, Sena Taskin, Ozge Selcuk, Begum Celik, Ece Tumkaya, Abdulilah Ece, Hayati Sari, Zeynel Seferoglu, Furkan Ayaz, Yahya Nural

Structure-Guided Design and Synthesis of ATP-competitive NAcyl-substituted Sulfamide D-Alanine-D-Alanine Ligase Inhibitors: (2023) Rouven Becker, Jordan L. Pederick, Edward G. Dawes, John B. Bruning, Andrew D. Abell

Discovery of a potent and selective human AC2 inhibitor based on 7-deazapurine analogues of adefovir: (2023) Pavel Kraina, Michal Česnek, Eva Tloušťová, Helena Mertlíková-Kaiserová, Camryn J. Fulton, Emily K. Davidson, Brenton P. Smith, Val J. Watts, Zlatko J...

Development of decoy oligonucleotide-warheaded chimeric molecules targeting STAT3: (2023) Po-Chang Shih, Miyako Naganuma, Genichiro Tsuji, Yosuke Demizu, Mikihiko Naito

Probing a distinct druggable tubulin binding site with gatorbulins 1–7, their metabolic and physicochemical properties, and pharmacological consequences: (2023) Qi-Yin Chen, Ranjala Ratnayake, Rafael Hortigüela, Gustavo M. Seabra, Michael D. Cameron, J. Fernando Díaz, María Ángela Oliva, Hendrik Luesch

认证评论

注：认证评论选取于全球各个学术评论平台和社交媒体。

4.8 submission, 5.16 first-round revision, 6.8 final revision, 6.20 acceptance. The revised version did not include additional experiments, but all the reviewer's comments were diligently addressed. The revision took longer due to the vacation and the pandemic of our overseas collaborators. BMC is relatively more classic, but in the past two years, medical journals have been rapidly rising, and BMC has not benefitted from this trend. Those working on tuberculosis can refer to our article 10.1016/j.bmc.2022.116896 more frequently.

2022-08-24

4.17 submitted; 5.10 minor revisions after initial review; 5.22 revised; 6.22 accepted. There were some minor mistakes during the editing process, which delayed the acceptance time by about a week. Overall, the review process was relatively fast and the editor was very nice. The data requirements are comprehensive, and it is one of the more prestigious journals in the field of medicinal chemistry. We hope that the impact factor (IF) for the year 2022 can increase.

2022-06-28

查看所有评论

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started